Mukherjea’s answer: A balanced portfolio—one-third every in Indian equities, US smallcaps and midcaps, and gold.
On this interview with Mint, Mukherjea, certainly one of India’s most carefully watched fund managers, additionally mentioned the US tariffs, its affect on Indian jobs, and home sectors the place he nonetheless sees alternatives. Edited excerpts:
The previous yr’s been a whirlwind of geopolitical tensions and market swings, but the Nifty hasn’t moved a lot. With returns being fairly muted and buyers staying cautious, what do you see as key dangers and alternatives for Indian equities within the coming yr?
The most important problem for India proper now could be that earnings and revenue progress have slowed sharply during the last two years, primarily as a result of white-collar job creation has stalled—even shrinking with IT layoffs. Round 40 million white-collar employees not directly help one other 200 million in providers, forming the spine of India’s consumption engine.
With jobs drying up, consumption, which is 60% of GDP, has obtained jammed, which implies earnings progress has slowed. And with earnings not rising, it’s powerful for a market already buying and selling at record-high valuations to maneuver any additional—that’s the core problem.
With earnings not rising, it’s powerful for a market already buying and selling at record-high valuations to maneuver any additional.
That mentioned, the federal government has responded with tax cuts, GST cuts, RBI (Reserve Financial institution of India) fee cuts, and a consumption push. However it’ll take a number of quarters to point out outcomes. The deeper problem stays: AI (synthetic intelligence) and automation are decreasing the necessity for white-collar employees, and in a labour-heavy nation like India, that’s a structural downside.
Valuations are steep, which is why the market is struggling to maneuver forward.
How do you view the present geopolitical and macroeconomic panorama?
Higher alternatives lie overseas. US and European small- and mid-caps have delivered double India’s earnings progress over time at half the valuations. Regardless of Western volatility, this makes a robust case for diversification.
Because of GIFT Metropolis, investing in Western equities is now cost- and tax-efficient. At Marcellus, we constructed a Western equities staff over three years in the past, and many people now maintain half our fairness investments in these markets. Over the long term, each India and the US ship 10–11% greenback returns with low correlation, making a 50-50 fairness portfolio much more resilient.
At present, Western small- and mid-caps are particularly engaging: earnings progress averages 11–12% vs India’s 5.5–6%, whereas valuations are 15–25x vs India’s 30–50x. The mismatch—increased progress at decrease valuations—plus, Trump-era fears amongst Western buyers, creates a compelling alternative for international diversification.
India has been among the many worst-performing markets in recent times, delivering solely about 3% returns, lagging each European and US markets. How do you learn or interpret this development?
Each main free-market financial system goes by way of cycles. No nation, together with India or the US, strikes in a straight line. India had three robust years post-Covid (2021–23), however the financial system started to sluggish late final yr and hasn’t but recovered. The core job engine is caught, and it could take one other 4–6 quarters to show round.
The important thing level: when you keep invested in only one financial system, you’re using its full boom-and-bust cycle. Most buyers purchase at peaks and exit at lows. The answer is to diversify throughout economies with totally different cycles. As an example, whereas India has slowed, the US financial system stays robust with strong credit score progress, job creation, and record-high markets.
India had three robust years post-Covid, however the financial system started to sluggish late final yr and hasn’t but recovered.
These absolutely invested in India have had a tricky yr, whereas these with a balanced India-US portfolio have fared higher. The identical logic utilized to US buyers between 1967 and 1984—US equities gave zero returns in these years.
That’s why a 50-50 allocation between India and the US is sensible. It helps you earn steadily, cut back stress, realizing your portfolio is balanced and performing.
What about different markets?
Different fairness markets don’t supply the identical low correlation with India because the US does. For instance, India and different growing international locations are extra tightly correlated as a consequence of comparable rising market dynamics, whereas India and the US differ considerably—tech-driven vs labour-driven economies; parliamentary vs presidential techniques; market-led vs bank-led monetary techniques; and revenue ranges. These variations make the US fairness markets a super diversifier.
What’s your tackle different markets, and the way do you view gold and silver, which have surged over 50% previously yr?
Truly, gold is one other diversifier. Its correlation with India is low, although long-term returns (6–7% in {dollars}) are decrease than US equities (10–11%). A portfolio cut up [across] roughly one-third India, one-third US, one-third gold can ship 12–13% greenback returns (14–15% in rupees) with decrease volatility.
Nevertheless, gold is presently costly as a consequence of international threat fears—Trump, geopolitical tensions, and Center East conflicts. So it’s higher to attend for a value drop earlier than growing allocation.
Should you already maintain Indian equities and gold, make them one-third every, and allocate the ultimate third to US small- and mid-caps.
For diversification at this time, when you already maintain India and gold, make them one-third every, and allocate the ultimate third to US small- and mid-caps, that are buying and selling at a 26-year low relative to the S&P 500. Should you solely maintain Indian equities, diversify 50% India, 50% US small/mid-caps, and look ahead to a greater time so as to add gold.
Are you suggesting it is likely to be sensible to chop again on gold publicity?
If you have already got gold and it’s greater than a 3rd of your portfolio, deliver it down. The bulletproof portfolio can be: India one-third (Nifty 50), US one-third (S&P small- and mid-cap), and gold one-third.
Saurabh Mukherjea’s funding technique
Assume international: Don’t rely solely on India—allocate a part of your portfolio to U.S. and European equities.
Three-pronged portfolio: One-third Indian equities, one-third U.S. small/mid-caps, one-third gold balances progress and threat.
Focused alternatives: Healthcare, prime non-public banks, and consumer-driven sectors nonetheless present robust potential.
Gold as a hedge: Retains portfolio resilient, however look ahead to value corrections earlier than growing allocation.
Home challenges: Be cautious of the slowdown in white-collar jobs in India; it is slowing consumption and company earnings.
How do you see returns from right here? Ought to buyers reasonable expectations, brace for a surge, or give attention to lifelike compounding?
It relies upon available on the market. As a worldwide investor, a diversified portfolio throughout India, the US, and gold can nonetheless ship double-digit greenback returns over the following 3–4 years. However when you stick solely to India, which is simply 3% of world market cap, the following few years could possibly be powerful.
Earnings progress seems to be weak, and the job market is rebalancing in India. The standard white-collar employment mannequin is fading, and India is transitioning to an expert gig financial system, enabled by low-cost broadband, UPI, and GST.
Throughout this transition, earnings progress and inventory market returns could stay subdued, however that’s not an issue when you diversify globally.
The standard white-collar employment mannequin is fading, and India is transitioning to an expert gig financial system.
Do you suppose the commerce tensions with the US may probably sluggish earnings progress?
I do suppose India and the US will finally attain an FTA (free commerce settlement), however till then, the 50% tariffs imposed by the US are hurting employees. I noticed the affect firsthand in Tirupur and Jap UP (Uttar Pradesh)—textiles, handmade carpets, gems and jewelry, leather-based, jute, and sports activities items are all disrupted, affecting 20–30 million employees.
Except reduction comes by November, these tariffs may result in job losses and drag down consumption. The federal government’s consumption stimulus could kick in over the following 3–6 months, however a big half could possibly be offset by the tariffs.
Are there any sectors or alternatives the place you’re discovering contemporary concepts? Or are you primarily including to the winners already in your portfolio?
We’ve been actively investing in home healthcare for the previous 7–8 years and proceed to seek out alternatives there. With the Ayushman Bharat scheme (public medical insurance) and employer-provided Medicare, most healthcare can be delivered by the non-public sector, benefiting hospitals, diagnostics, medical units, and pharma.
The second focus is on the highest three banks—HDFC, ICICI, and SBI. The banking sector is prone to grow to be a three-horse race, with others fading. Non-performing belongings could rise elsewhere as a consequence of white-collar job losses, however these three banks ought to carry out nicely, forming 30% of the index. We’ve invested in HDFC Financial institution and ICICI Financial institution in varied portfolios.
We’ve been actively investing in home healthcare for the previous 7–8 years and proceed to seek out alternatives there.
The third space is consumption, boosted by a authorities stimulus of round $80 billion (1.7% of GDP) over the following 3–4 quarters, benefiting FMCG (fast-moving client items), autos, and client durables.
Conversely, authorities capex (capital expenditure) will stay weak as a consequence of falling tax collections and monetary recalibration, pressuring shares tied to PSUs (public sector undertakings, or state-run corporations), contractors, protection, railways, and roadbuilders.
In gentle of the US tariffs, you maintain Carysil and about 27% of the corporate’s income come from the US. Are you decreasing your publicity to Carysil or seeking to improve it?
Carysil (a Mumbai-based maker of kitchen sinks) has carried out very nicely for us, doubling within the final 12 months. Round 25–30% of its income comes from US exports, primarily quartz sinks, that are high-quality however 30–40% cheaper than German opponents like Schock. World retailers comparable to Ikea and the US firm Karan supply from them.
We purchased [shares in] Carysil two years in the past, and whereas home consumption seems to be robust, the US tariff scenario is regarding. Given the excessive valuations and inventory run-up, now we have tapered our place over the previous month.
Wanting on the broader image, do you suppose the Indian market is presently forward of its fundamentals?
Sure, that’s typical. After 2020–21, individuals began investing closely post-lockdowns. Even because the financial system slowed two years in the past, mutual fund inflows remained robust at $30–40 billion yearly, making a disconnect between excessive valuations and weak fundamentals. Retail participation can be at a file excessive.
Any misses you’d admit to; a inventory you had your eye on however couldn’t get into?
We’ve missed out on the outsourced manufacturing area. We’ve watched Dixon Applied sciences with admiration for years however by no means managed to get in. It’s a strong firm—one I want we’d noticed earlier. For my part, the outsourced electronics business at this time is the place outsourced pharma was 20–25 years in the past.

**flow force max**
flow force max delivers a forward-thinking, plant-focused way to support prostate health—while also helping maintain everyday energy, libido, and overall vitality.
**prodentim**
prodentim is a forward-thinking oral wellness blend crafted to nurture and maintain a balanced mouth microbiome.
**cellufend**
cellufend is a natural supplement developed to support balanced blood sugar levels through a blend of botanical extracts and essential nutrients.